Publications by authors named "Weichen Dai"

Claim this Profile
D
Discovery of SILA-123 as a Highly Potent FLT3 Inhibitor for the Treatment of Acute Myeloid Leukemia with Various FLT3 Mutations.
Tian-Hua Wei, Zi-Xuan Wang, Meng-Yi Lu, Yu-Jing Xu, Jin Yang, Wei-Chen Dai

J Med Chem· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis, and Biological Activities Evaluation of Type I FLT3 Inhibitors for the Treatment of Acute Myeloid Leukemia.
Jin Yang, Yan Zhang, Yue-Chu Li, Qing-Xin Wang, Meng-Yuan Zhang, Wei-Chen Dai

Drug Dev Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 1-(Phenylsulfonyl)-1,2,3,4-tetrahydroquinoline Derivative as Orally Bioavailable and Safe RORγt Inverse Agonists for Potential Treatment of Rheumatoid Arthritis.
Shan-Liang Sun, Hong-Jiang Xu, Xiao-Long Jiang, Jian Zhou, Wei Shi, Wei-Chen Dai

J Med Chem· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring drug repositioning possibilities of kinase inhibitors via molecular simulation.
Qing-Xin Wang, Jiao Cai, Zi-Jun Chen, Jia-Chuan Liu, Jing-Jing Wang, Wei-Chen Dai

Mol Inform· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-coding RNAs as therapeutic targets in cancer and its clinical application.
Xuejiao Leng, Mengyuan Zhang, Yujing Xu, Jingjing Wang, Ning Ding, Weichen Dai

J Pharm Anal· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research strategies of small molecules as chemotherapeutics to overcome multiple myeloma resistance.
Jin Yang, Yan-Cheng Yu, Zi-Xuan Wang, Qing-Qing Li, Ning Ding, Wei-Chen Dai

Eur J Med Chem· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations.
Zi-Xuan Wang, Qing-Qing Li, Jiao Cai, Jia-Zhen Wu, Jing-Jing Wang, Wei-Chen Dai

J Med Chem· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis 1H-Pyrrolo[2,3-b]pyridine derivatives as FLT3 inhibitors for the treatment of Acute myeloid Leukemia.
Tian-Hua Wei, Yun Zhou, Jin Yang, Meng-Yuan Zhang, Jing-Jing Wang, Wei-Chen Dai

Bioorg Med Chem· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical characterization of danatinib as a novel FLT3 inhibitor with excellent efficacy against resistant acute myeloid leukemia.
Shan-Liang Sun, Jia-Zhen Wu, Jing-Jing Wang, Hai Zhou, Chen-Qian Zhang, Wei-Chen Dai

Biomed Pharmacother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain-Machine Coupled Learning Method for Facial Emotion Recognition.
Dongjun Liu, Weichen Dai, Hangkui Zhang, Xuanyu Jin, Jianting Cao

IEEE Trans Pattern Anal Mach Intell· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 4-(4-aminophenyl)-6-phenylisoxazolo[3,4-b]pyridine-3-amine derivatives as novel FLT3 covalent inhibitors for the intervention of acute myeloid leukemia.
Qing-Xin Wang, Yi-Bo Wang, Jiu-Kai Sha, Hai Zhou, Jia-Chuan Liu, Wei-Chen Dai

Drug Dev Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of selective FLT3 inhibitors via exploration of back pocket II.
Qing-Xin Wang, Yu-Hao Cao, Li-Jin Yang, Yi-Yuan Ma, Nan Li, Wei-Chen Dai

Future Med Chem· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LiDAR Intensity Completion: Fully Exploiting the Message from LiDAR Sensors.
Weichen Dai, Shenzhou Chen, Zhaoyang Huang, Yan Xu, Da Kong

Sensors (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of 4-(4-aminophenyl)-6-methylisoxazolo[3,4-b] pyridin-3-amine covalent inhibitors as potential agents for the treatment of acute myeloid leukemia.
Ji-Bo Kang, Lu Chen, Xue-Jiao Leng, Jing-Jing Wang, Yang Cheng, Wei-Chen Dai, Xiao-Bin Dai

Bioorg Med Chem· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RGB-D SLAM in Dynamic Environments Using Point Correlations.
Weichen Dai, Yu Zhang, Ping Li, Zheng Fang, Sebastian Scherer

IEEE Trans Pattern Anal Mach Intell· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Taccalonolide AJ-Hydroxypropyl-β-Cyclodextrin Inclusion Complexes for Treatment of Clear Cell Renal-Cell Carcinoma.
Jing Han, Siwang Zhang, Junxin Niu, Chunli Zhang, Weichen Dai

Molecules· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-pot synthesis of indoles and quinolinones from -tosylaminophenyl-substituted -quinone methides.
Junwei Wang, Xiang Pan, Quanjin Rong, Lei Zhao, Lin Zhao, Weichen Dai

RSC Adv· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Orally Active Thrombin Inhibitors for the Treatment of Thrombotic Disorder Diseases.
Li-Wei He, Wei-Chen Dai, Nian-Guang Li

Molecules· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis